Market Access in Japan: New Challenges and Opportunities for the Pharmaceutical IndustryDecision Resources
July 20, 2010
40 Pages - SKU: DECR2750752
Additional InformationCompanies Mentioned in This Report:
Daiichi Sankyo Espha
Meiji Seika Kaisha
Sanofi -Aventis Nichi-Iko
Taisho Pharmaceutical Industries
Key Terms for This Report:
Biosimilars, Cost-calculation method, Cost containment, Generics, Health technology assessment, Health economic evaluation, Long-listed drugs, Market access, Pharmaceutical pricing, Price cuts, Price premiums, Price revision, Reimbursement, Repricing, Similar-effi cacy comparison
More Pricing reports by Decision Resources
Turkey: Market Access Tracker by Decision Resources
The Turkish pharmaceutical market is the 6th largest in Europe and the 16th largest in the world and experienced rapid growth until 2011. A ...
Italy: Market Access Tracker by Decision Resources
The Italian pharmaceutical market is the third largest in Europe and the eighth largest in the world, with ex-manufacturer sales in retail pharmacies ...
Europe: Market Access Tracker by Decision Resources
Decision Resources’ Market Access Tracker service for Europe explains the challenges and opportunities to gaining and maintaining favorable market access terms in the mature and ...
China: Market Access Tracker by Decision ResourcesSee all reports like this >>
Decision Resources’ Market Access Tracker service for the Asia Pacific region explains the challenges and opportunities to gaining and maintaining favorable market access terms in ...
More Japan Pricing reports
Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins by GBI Research
Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit MarginsSummaryLeading business intelligence provider GBI Research ...
The Pharmaceutical Market: Japan by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Healthcare, Regulatory and Reimbursement Landscape - Japan by GlobalData
Japan: Pricing, Reimbursement and Regulatory Update by DatamonitorSee all reports like this >>
IntroductionStimulating innovation is a top priority in Japan, with the government having brought in a range of incentives in 2011, many of which will have ...
More Japan reports
D&B Country Report: Japan by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Pharmaceuticals Company Reports
- Generics Drugs
- Manufacturing, Packaging & Detailing
- Regulation & Policy
- Prescription Drugs
- Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals
- Generic And Innovative Drugs Market In Central Europe 2013
- Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players
- Healthcare, Regulatory and Reimbursement Landscape - Finland
- Healthcare, Regulatory and Reimbursement Landscape - Austria